Literature DB >> 15848758

Structure-affinity relationship studies on arylpiperazine derivatives related to quipazine as serotonin transporter ligands. Molecular basis of the selectivity SERT/5HT3 receptor.

Andrea Cappelli1, Germano Giuliani, Andrea Gallelli, Salvatore Valenti, Maurizio Anzini, Laura Mennuni, Francesco Makovec, Aroldo Cupello, Salvatore Vomero.   

Abstract

A series of quipazine derivatives, previously synthesized to probe the 5-HT(3) receptor, was evaluated for its potential interaction with serotonin transporter (SERT). Some of them show nanomolar affinity for the rodent SERT comparable to or slightly higher than quipazine or N-methylquipazine. Subsequently a candidate was selected on the basis of its SERT affinity and submitted to a molecular manipulation of the basic moiety. The structure-affinity relationships obtained provided information on the role of the fused benzene ring of quipazine in the interaction with the SERT binding site and on the stereoelectronic requirements for the interaction of both the heteroaromatic component and the basic moiety. Moreover, the comparison of the structure-affinity relationships obtained in the present work with those concerning the interaction of these heteroarylpiperazine derivatives with 5-HT3 receptor suggested some molecular determinants of the selectivity SERT/5HT3 receptor.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15848758     DOI: 10.1016/j.bmc.2005.03.008

Source DB:  PubMed          Journal:  Bioorg Med Chem        ISSN: 0968-0896            Impact factor:   3.641


  5 in total

1.  Synthesis, in vitro binding studies and docking of long-chain arylpiperazine nitroquipazine analogues, as potential serotonin transporter inhibitors.

Authors:  Małgorzata Jarończyk; Karol Wołosewicz; Mari Gabrielsen; Gabriel Nowak; Irina Kufareva; Aleksander P Mazurek; Aina W Ravna; Ruben Abagyan; Andrzej J Bojarski; Ingebrigt Sylte; Zdzisław Chilmonczyk
Journal:  Eur J Med Chem       Date:  2012-01-15       Impact factor: 6.514

2.  Successful treatment of epilepsy with serotonin reuptake inhibitors: proposed mechanism.

Authors:  C Albano; A Cupello; P Mainardi; S Scarrone; E Favale
Journal:  Neurochem Res       Date:  2006-05-13       Impact factor: 3.996

3.  Is the platelet serotonin transporter different in venous vs. arterial blood?

Authors:  Emiliano Villa; Claudio Albano; Andrea Cappelli; Emilio Favale; Emilia Fugassa; Ezio Gerdoni; Simona Scarrone; Aroldo Cupello
Journal:  Neurochem Res       Date:  2005-11       Impact factor: 3.996

4.  Enantiomeric impurities in chiral synthons, catalysts, and auxiliaries. Part 3.

Authors:  Ke Huang; Zachary S Breitbach; Daniel W Armstrong
Journal:  Tetrahedron Asymmetry       Date:  2006-10-27

5.  Psychedelic-like Properties of Quipazine and Its Structural Analogues in Mice.

Authors:  Mario de la Fuente Revenga; Urjita H Shah; Nima Nassehi; Alaina M Jaster; Prithvi Hemanth; Salvador Sierra; Malgorzata Dukat; Javier González-Maeso
Journal:  ACS Chem Neurosci       Date:  2021-01-05       Impact factor: 4.418

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.